A1CNOW FOR RX HOME USE— 510(k) K020234

Substantially Equivalent

Metrika, Inc.

FDA 510(k) clearance K020234 for A1CNOW FOR RX HOME USE, Substantially Equivalent on 2002-02-15. Applicant: Metrika, Inc.. Device class: 2.

Clearance details

Applicant: Metrika, Inc.
Product code: Code LCP
Device class: Class 2
Regulation: 21 CFR 864.7470
Advisory panel: Hematology
Date received: 2002-01-23
Decision date: 2002-02-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Sunnyvale, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LCP

K221326 — Nova Allegro HbA1c Assay, Nova Allegro Analyzer2024-11-22
K231465 — Q-Pad Test System2023-12-06
K214117 — Afinion HbA1c, Afinion 2 and Alere Afinion AS100 Analyzer2023-09-27
K192987 — Aina HbA1c Monitoring System 22020-03-26
K192369 — PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test Kit2019-10-29

More clearances from Metrika, Inc.

K051321 — INVIEW2005-06-13
K033847 — A1CNOW FOR HOME AND PROFESSIONAL USE2003-12-23
K022661 — A1CNOW FOR HOME USE2002-12-13
K020235 — A1CNOW FOR PROFESSIONAL USE2002-02-15
K000885 — DRX HBA1C - FOR PRESCRIPTION HOME USE2000-09-26

Data sourced from openFDA. This site is unofficial and independent of the FDA.